David K. Lee - Dec 5, 2023 Form 3 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role
Director
Signature
/s/ Adi Osovsky, as Attorney-in-Fact
Stock symbol
ITOS
Transactions as of
Dec 5, 2023
Transactions value $
$0
Form type
3
Date filed
12/7/2023, 08:16 PM
Next filing
Jun 13, 2024

No securities are beneficially owned.